Reema Sheth
NPI: 1265824551
Total Payments
$88,918
2024 Payments
$2,176
Companies
31
Transactions
298
Medicare Patients
4,330
Medicare Billing
$507,215
Payment Breakdown by Category
Consulting$78,045 (87.8%)
Food & Beverage$6,231 (7.0%)
Travel$2,223 (2.5%)
Other$2,000 (2.2%)
Education$418.87 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $78,045 | 83 | 87.8% |
| Food and Beverage | $6,231 | 200 | 7.0% |
| Travel and Lodging | $2,223 | 9 | 2.5% |
| Grant | $2,000 | 1 | 2.2% |
| Education | $418.87 | 5 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| CSL Behring | $78,045 | 83 | $0 (2022) |
| Abbott Laboratories | $4,667 | 23 | $0 (2023) |
| Medtronic, Inc. | $1,560 | 30 | $0 (2024) |
| Boston Scientific Corporation | $487.46 | 12 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $449.18 | 12 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $446.09 | 9 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $329.14 | 17 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $306.98 | 16 | $0 (2024) |
| Amgen Inc. | $276.62 | 13 | $0 (2024) |
| Cardiovascular Systems Inc. | $251.57 | 6 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,176 | 52 | Medtronic, Inc. ($1,363) |
| 2023 | $885.08 | 34 | Novartis Pharmaceuticals Corporation ($178.72) |
| 2022 | $16,996 | 49 | CSL Behring ($14,190) |
| 2021 | $24,161 | 39 | CSL Behring ($23,540) |
| 2020 | $28,692 | 32 | CSL Behring ($26,565) |
| 2019 | $14,520 | 31 | CSL Behring ($13,750) |
| 2018 | $346.81 | 14 | Astellas Pharma US Inc ($89.99) |
| 2017 | $1,141 | 47 | Janssen Pharmaceuticals, Inc ($175.26) |
All Payment Transactions
298 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $22.55 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/11/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.82 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/10/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: Renal Denervation System | ||||||
| 11/22/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $8.43 | General |
| Category: Renal Denervation System | ||||||
| 11/20/2024 | Medtronic, Inc. | COREVALVE EVOLUT R (Device) | Food and Beverage | In-kind items and services | $42.57 | General |
| Category: Transcatheter Valve Systems | ||||||
| 11/13/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $25.78 | General |
| 11/12/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: Cardiology | ||||||
| 10/25/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: Renal Denervation System | ||||||
| 10/22/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $12.78 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/06/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: Renal Denervation System | ||||||
| 08/27/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/20/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $17.11 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 08/13/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: Renal Denervation System | ||||||
| 08/13/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $13.11 | General |
| Category: Cardiovascular | ||||||
| 07/31/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/17/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.52 | General |
| Category: Obesity | ||||||
| 06/27/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: Renal Denervation System | ||||||
| 06/18/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: Cardiology | ||||||
| 06/15/2024 | Medtronic, Inc. | VENASEAL (Device) | Travel and Lodging | In-kind items and services | $56.80 | General |
| Category: EndoVenous Therapies | ||||||
| 06/14/2024 | Medtronic, Inc. | VENASEAL (Device) | Travel and Lodging | In-kind items and services | $378.00 | General |
| Category: EndoVenous Therapies | ||||||
| 06/12/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.46 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/02/2024 | Medtronic, Inc. | VENASEAL (Device) | Food and Beverage | In-kind items and services | $40.85 | General |
| Category: EndoVenous Therapies | ||||||
| 06/02/2024 | Medtronic, Inc. | VENASEAL (Device) | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: EndoVenous Therapies | ||||||
| 06/02/2024 | Medtronic, Inc. | VENASEAL (Device) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: EndoVenous Therapies | ||||||
| 06/01/2024 | Medtronic, Inc. | VENASEAL (Device) | Food and Beverage | In-kind items and services | $143.69 | General |
| Category: EndoVenous Therapies | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 31 | 3,706 | 4,943 | $1.7M | $438,046 |
| 2022 | 8 | 624 | 769 | $323,311 | $69,169 |
Total Patients
4,330
Total Services
5,712
Medicare Billing
$507,215
Procedure Codes
44
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 769 | 1,347 | $210,132 | $87,673 | 41.7% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 188 | 189 | $400,869 | $67,677 | 16.9% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 188 | 378 | $113,400 | $61,252 | 54.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 237 | 241 | $72,300 | $25,715 | 35.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 420 | 425 | $127,500 | $22,795 | 17.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 147 | 182 | $29,848 | $18,803 | 63.0% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 114 | 460 | $46,000 | $18,096 | 39.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 130 | 130 | $117,000 | $17,878 | 15.3% |
| 93454 | Insertion of tube in coronary artery for diagnosis with review by radiologist | Facility | 2023 | 95 | 96 | $96,000 | $17,196 | 17.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 89 | 91 | $38,675 | $13,022 | 33.7% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 23 | 26 | $91,000 | $12,744 | 14.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 59 | 77 | $18,249 | $11,334 | 62.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 90 | 105 | $23,520 | $10,306 | 43.8% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 44 | 44 | $59,400 | $9,712 | 16.4% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 188 | 189 | $85,050 | $9,566 | 11.2% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 122 | 122 | $39,040 | $7,236 | 18.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 43 | 45 | $7,380 | $3,574 | 48.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 19 | 19 | $6,517 | $3,482 | 53.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 26 | 26 | $7,046 | $3,425 | 48.6% |
| 93455 | Insertion of tube in bypass graft for diagnosis with review by radiologist | Facility | 2023 | 14 | 14 | $14,000 | $2,691 | 19.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 33 | 37 | $3,885 | $2,499 | 64.3% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 127 | 127 | $14,605 | $2,107 | 14.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 16 | 16 | $4,336 | $1,764 | 40.7% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 144 | 150 | $6,150 | $1,591 | 25.9% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 127 | 127 | $20,320 | $1,398 | 6.9% |
About Reema Sheth
Reema Sheth is a Student in an Organized Health Care Education/Training Program healthcare provider based in Palos Park, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/24/2015. The National Provider Identifier (NPI) number assigned to this provider is 1265824551.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Reema Sheth has received a total of $88,918 in payments from pharmaceutical and medical device companies, with $2,176 received in 2024. These payments were reported across 298 transactions from 31 companies. The most common payment nature is "Consulting Fee" ($78,045).
As a Medicare-enrolled provider, Sheth has provided services to 4,330 Medicare beneficiaries, totaling 5,712 services with total Medicare billing of $507,215. Data is available for 2 years (2022–2023), covering 44 distinct procedure/service records.
Ad
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Cardiovascular Disease
- Location Palos Park, IL
- Active Since 02/24/2015
- Last Updated 08/28/2022
- Taxonomy Code 390200000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1265824551
Products in Payments
- AMPLATZER AMULET (Device) $2,191
- VENASEAL (Device) $1,211
- LEQVIO (Drug) $449.18
- LifeVest (Device) $329.14
- WATCHMAN (Device) $320.51
- SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER (Device) $237.93
- ELIQUIS (Drug) $234.10
- FARXIGA (Drug) $226.99
- XARELTO (Drug) $207.33
- Repatha (Biological) $205.67
- Diamondback Coronary (Device) $200.70
- Confirm Rx (Device) $184.59
- CAMZYOS (Drug) $183.88
- NEXLETOL (Drug) $161.45
- DALVANCE (Drug) $136.89
- Pacemakers (Device) $136.19
- Allure Quadra RF CRT Pacemaker (Device) $133.14
- JARDIANCE (Drug) $130.83
- SYMPLICITY G3 (Device) $109.70
- BRILINTA (Drug) $104.77
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.